Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country Sort ascending
Application Due Date
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines Italy
Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Ghana
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
Release Date:
Partner: Arvinas
Review Process: Pfizer Internal
Education Oncology All
Addressing Knowledge Gaps in Aplastic Anemia
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Title
Grant Type
Focus Area
Country Sort ascending
Application Due Date
Topical Hemostasis in Minimally Invasive Surgery
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Artificial Intelligence/Machine Learning Research in Hemophilia
Release Date:
Review Process: Expert Review Panel
Research Rare Disease USA
Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
2021 Fellowship for Inflammatory Dermatological Diseases
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
2021 Inflammatory Bowel Disease (IBD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Atopic Dermatitis Patient Education
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Adoption of Biosimilars in Oncology
Release Date:
Partner:

The National Comprehensive Cancer Network® (NCCN)

Review Process: Expert Review Panel
Research Oncology USA
Use of Biosimilar Agents in Inflammatory Conditions
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Pediatric Endocrinology Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Local Level Educational Grants Program to Increase Awareness and Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA